NEW YORK (GenomeWeb News) – Though Thermo Fisher Scientific's pending $13.6 billion purchase of Life Technologies sent shockwaves through the industry and led some to speculate about further deals, mergers and acquisitions in the life science tools and molecular diagnostics space were down year over year in 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.